24 reports

  • Global gastrointestinal stents market 2015-2020 ($ millions)
  • Global pulmonary stents market

Statistics given by WHO indicate that approximately ## million individuals have asthma and around ##, ## deaths were attributed to asthma in 2007.

  • Interventional Cardiology Device
  • World
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Medtronic, Inc.

THE COMPANY' S PROPRIETARY PLATFORM TECHNOLOGY IS APPLIED IN VARIOUS THERAPEUTIC AREAS SUCH AS CANCER, PAIN, ASTHMA, INFLAMMATION, SEPSIS AND OTHERS.

  • Interventional Cardiology Device
  • Latin America
  • Mexico
  • North America
  • Forecast

THE COMPANY' S PROPRIETARY PLATFORM TECHNOLOGY IS APPLIED IN VARIOUS THERAPEUTIC AREAS SUCH AS CANCER, PAIN, ASTHMA, INFLAMMATION, SEPSIS AND OTHERS.

  • Interventional Cardiology Device
  • Australasia
  • Australia
  • Oceania
  • Forecast
  • Global Pulmonary Stents Market, 2013 - 2019 Value (US$ Millions)

The company Ella-CS is based out of Eastern European republic of Czech, and is one of the highest revenue generators in the market globally.

  • Interventional Cardiology Device
  • World
  • Forecast
  • Boston Scientific Corporation
  • Taewoong Medical

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Hospital
  • Interventional Cardiology Device
  • Company
  • Demand
  • InspireMD

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Interventional Cardiology Device
  • Medical Device
  • Boston Scientific Corporation

S. filing in persistent uncontrolled asthma expected to take place in Q##.

  • Cardiology
  • Catheter
  • Interventional Cardiology Device
  • France
  • Sanofi S.A.

FILING IN PERSISTENT UNCONTROLLED ASTHMA EXPECTED TO TAKE PLACE IN Q##.

  • Hospital
  • Interventional Cardiology Device
  • Southern Europe
  • Western Europe
  • Market Size

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Cardiovascular Devices
  • Clinical Trial
  • Hospital
  • Interventional Cardiology Device
  • Boston Scientific Corporation

" There are several new drugs for severe asthma that target the more allergic, or eosinophilic, type of severe asthma.

  • Healthcare
  • Interventional Cardiology Device
  • North America
  • United States
  • Market Size

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Health Services
  • Interventional Cardiology Device
  • Medical Device
  • North America
  • Market Size

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Hospital
  • Interventional Cardiology Device
  • Medical Device
  • Endologix, Inc.

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Interventional Cardiology Device
  • Medical Device
  • United States
  • Market Size
  • Corindus, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Hospital
  • Interventional Cardiology Device
  • Prosthesis
  • Boston Scientific Corporation

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Interventional Cardiology Device
  • Medical Device
  • Pharmaceutical
  • United States
  • Company

VR## GLOBAL, OUR CO-DEVELOPMENT WITH UCB OF A BIOLOGIC FOR UNCONTROLLED ASTHMA WITH ONE OF VECTURA' S PROPRIETARY DPI DEVICES CONTINUED TO MAKE PROGRESS.

  • Hospital
  • Interventional Cardiology Device
  • Northern Europe
  • United Kingdom
  • Forecast

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Clinical Trial
  • Interventional Cardiology Device
  • Medical Device
  • United States
  • Boston Scientific Corporation

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Cardiac Management
  • Interventional Cardiology Device
  • Patient Monitoring
  • United States
  • Boston Scientific Corporation

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Cardiology
  • Clinical Trial
  • Drug Discovery And Development
  • Interventional Cardiology Device
  • GlobalData's company

The Global Asthma Report 2014 by Global Asthma Network (GAN) estimates that around ## million people globally were suffering from asthma in 2012.

  • Interventional Cardiology Device
  • North America
  • United States
  • World
  • Market Size

ABBVIE AND BOEHRINGER INGELHEIM ALSO ARE EVALUATING THE POTENTIAL OF THIS BIOLOGIC THERAPY IN CROHN' S DISEASE, PSORIATIC ARTHRITIS AND ASTHMA.

  • Body Contouring Device
  • Interventional Cardiology Device
  • North America
  • United States
  • Forecast

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Implantable Delivery
  • Interventional Cardiology Device
  • Medical Device
  • REVA Medical, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Interventional Cardiology Device
  • Medical Equipment
  • Pharmaceutical
  • Company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Cardiology
  • Clinical Trial
  • Implantable Delivery
  • Interventional Cardiology Device
  • Medtronic, Inc.